New ultra-short-acting β-blockers: Landiolol and esmolol - The effects on cardiovascular system

Japanese Journal of Anesthesiology

Volumn 55, Issue 7, 2006, Pages 841-848

  Mio, Yasushi ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Esmolol; Heart; Landiolol

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ESMOLOL; LANDIOLOL; PROPRANOLOL; SHORT ACTING DRUG;

BETA ADRENERGIC RECEPTOR BLOCKING; CARDIOSELECTIVITY; CARDIOVASCULAR SYSTEM; CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG SAFETY; ENDOTRACHEAL INTUBATION; HEART MUSCLE ISCHEMIA; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEART WORK; HIGH RISK POPULATION; HUMAN; HYPERTENSION; INCISION; ISCHEMIC HEART DISEASE; PERIOPERATIVE PERIOD; PROPHYLAXIS; REVIEW; TACHYCARDIA; TITRIMETRY;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; HEART RATE; HUMANS; MORPHOLINES; MYOCARDIAL ISCHEMIA; PROPANOLAMINES; UREA;

EID: 33746252988     PISSN: 00214892     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Sugiyama A, Takahara A, Hashimoto K. Electrophysiologic, cardiohemodynamic and β-blocking actions of a new ultra-short-acting β-blocker, ONO-1011, assessed by the in vivo canine model in comparison with esmolol. J Cardiovasc Pharmacol 1999; 34: 70-7.
2. Sasao J, Tarver SD, Kindscher JD, Taneyama C, Benson KT, Goto H. In rabbits, landiolol, a new ultra-short-acting beta-blocker, exerts a more potent negative chronotropic effect and less effect on blood pressure than esmolol. Can J Anaesth 2001; 48: 985-9.
3. Iguchi S, Iwamura H, Nishizaki M, Hayashi A, Senokuchi K, Kobayashi S, et al. Development of a highly cardioselective ultra short-acting beta-blocker, ONO-1101. Chem Pharm Bull (Tokyo) 1992; 40: 1462-9.
4. Askenazi J, MacCosbe PE, Hoff J, Turlapaty P, Hua TA, Laddu A. Hemodynamic effects of esmolol, an ultrashort-acting beta blocker. J Clin Pharmacol 1987; 27: 567-73.
5. Reilly CS, Wood M, Koshakji RP, Wood AJ. Ultra-short-acting beta-blockade: a comparison with conventional beta-blockade. Clin Pharmacol Ther 1985; 38: 579-85.
6. Iskandrian AS, Bemis CE, Hakki AH, Panidis I, Heo J, Toole JG, et al. Effects of esmolol on patients with left ventricular dysfunction. J Am Coll Cardiol 1986; 8: 225-31.
7. Sum CY, Yacobi A, Kartzinel R, Stampfli H, Davis CS, Lai CM. Kinetics of esmolol, an ultra-short-acting beta blocker, and of its major metabolite. Clin Pharmacol Ther 1983; 34: 427-34.
8. Reynolds RD, Gorczynski RJ, Quon CY. Pharmacology and pharmacokinetics of esmolol. J Clin Pharmacol 1986; 26: A 3-14.
9. Buchi KN, Rollins DE, Tolman KG, Achari R, Drissel D, Hulse JD. Pharmacokinetics of esmolol in hepatic disease. J Clin Pharmacol 1987; 27: 880-4.
10. Takahata T, Yasui-Furukori N, Sakamoto J, Suto K, Suto T, Tateishi T, et al. Influence of hepatic impairment on the pharmacokinetics and pharmacodynamics of landiolol hydrochloride, an ultra-short-acting beta 1-blocker. Drugs RD 2005; 6: 385-94.
11. Flaherty JF, Wong B, La Follette G, Warnock DG, Hulse JD, Gambertoglio JG. Pharmacokinetics of esmolol and ASL-8123 in renal failure. Clin Pharmacol Ther 1989; 45: 321-7.
12. Gold MI, Brown M, Coverman S, Herrington C. Heart rate and blood pressure effects of esmolol after ketamine induction and intubation. Anesthesiology 1986; 64: 718-23.
13. Dyson A, Isaac PA, Pennant JH, Giesecke AH, Lipton JM. Esmolol attenuates cardiovascular responses to extubation. Anesth Analg 1990; 71: 675-8.
14. Yamazaki A, Kinoshita H, Shimogai M, Fujii K, Nakahata K, Hironaka Y, et al. Landiolol attenuates tachycardia in response to endotracheal intubation without affecting blood pressure. Can J Anaesth 2005; 52: 254-7.
15. Deegan R, He H, Wood AJ. β-adrenergic receptor-mediated release of norepinephrine in the human forearm. Clin Pharmacol Ther 1993; 54: 58-64.
16. Arlock P, Wohlfart B, Sjoberg T, Steen S. The negative inotropic effect of esmolol on isolated cardiac muscle. Scand Cardiovasc J 2005; 39: 250-4.
17. Gray RJ, Bateman TM, Czer LS, Conklin C, Matloff JM. Use of esmolol in hypertension after cardiac surgery. Am J Cardiol 1985; 56: 49 F-56 F.
18. Platia EV, Michelson EL, Porterfield JK, Das G. Esmolol versus verapamil in the acute treatment of atrial fibrillation or atrial flutter. Am J Cardiol 1989; 63: 925-9.
19. Kirshenbaum JM, Kloner RF, McGowan N, Antman EM. Use of an ultrashort-acting beta-receptor blocker (esmolol) in patients with acute myocardial ischemia and relative contraindications to beta-blockade therapy. J Am Coll Cardiol 1988; 12: 773-80.
20. Barth C, Ojile M, Pearson AC, Labovitz AJ. Ultra short-acting intravenous beta-adrenergic blockade as add-on therapy in acute unstable angina. Am Heart J 1991; 121: 782-8.
21. Reves JG, Croughwell ND, Hawkins E, Smith LR, Jacobs JR, Rankin S, et al. Esmolol for treatment of intraoperative tachycardia and/or hypertension in patients having cardiac operations. Bolus loading technique. J Thorac Cardiovasc Surg 1990; 100: 221-7.
22. Wallace A, Layug B, Tateo I, Li J, Hollenberg M, Browner W, et al. Prophylactic atenolol reduces postoperative myocardial ischemia. McSPI Research Group. Anesthesiology 1998; 88: 7-17.
23. Eagle KA, Berger PB, Calkins H, Chaitman BR, Ewy GA, Fleischmann KE, et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery - Executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to update the 1996 guidelines on perioperative cardiovascular evaluation for noncardiac surgery). Anesth Analg 2002; 94: 1052-64.
24. Raby KE, Brull SJ, Timimi F, Akhtar S, Rosenbaum S, Naimi C, et al. The effect of heart rate control on myocardial ischemia among high-risk patients after vascular surgery. Anesth Analg 1999; 88: 477-82.
25. Urban MK, Markowitz SM, Gordon MA, Urquhart BL, Kligfield P. Postoperative prophylactic administration of beta-adrenergic blockers in patients at risk for myocardial ischemia. Anesth Analg 2000; 90: 1257-61.
26. Kurosawa S, Kanaya N, Niiyama Y, Nakayama M, Fujita S, Namiki A. Landiolol, esmolol and propranolol protect from ischemia/reperfusion injury in isolated guinea pig hearts. Can J Anaesth 2003; 50: 489-94.
27. Boldt J, Brosch C, Lehmann A, Suttner S, Isgro F. The prophylactic use of the beta-blocker esmolol in combination with phosphodiesterase III inhibitor enoximone in elderly cardiac surgery patients. Anesth Analg 2004; 99: 1009-17.